VCYT: Veracyte Inc
VCYT exchange rate has changed by -2.39% for today. During the day, the instrument was traded at a low of 33.1100 and at a high of 34.2800.
Follow Veracyte Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
VCYT News
- Veracyte CFO Chambers sells $662k in VCYT stock
- Morgan Stanley cuts Veracyte stock price target on valuation methodology
- Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre
- OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis
- GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery
- GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow
- Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises
- Veracyte stock price target raised to $48 by Needham on growth
- Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
- Veracyte Q4 2025 slides: 19% revenue growth, profitability soars
- FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
- Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
- Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation
- BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy
- AxoGen (AXGN) Q4 Earnings Miss Estimates
- ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
- Veracyte (VCYT) is a Top-Ranked Growth Stock: Should You Buy?
- GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio
- ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
- Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal
- GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound
- Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
- Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
- Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
Frequently Asked Questions
What is VCYT stock price today?
Veracyte Inc stock is priced at 33.8500 today. It trades within 33.1100 - 34.2800, yesterday's close was 34.6800, and trading volume reached 2629. The live price chart of VCYT shows these updates.
Does Veracyte Inc stock pay dividends?
Veracyte Inc is currently valued at 33.8500. Dividend policy depends on the company, while investors also watch -8.27% and USD. View the chart live to track VCYT movements.
How to buy VCYT stock?
You can buy Veracyte Inc shares at the current price of 33.8500. Orders are usually placed near 33.8500 or 33.8530, while 2629 and 1.53% show market activity. Follow VCYT updates on the live chart today.
How to invest into VCYT stock?
Investing in Veracyte Inc involves considering the yearly range 33.1100 - 50.7100 and current price 33.8500. Many compare -4.75% and -8.27% before placing orders at 33.8500 or 33.8530. Explore the VCYT price chart live with daily changes.
What are Veracyte Inc stock highest prices?
The highest price of Veracyte Inc in the past year was 50.7100. Within 33.1100 - 50.7100, the stock fluctuated notably, and comparing with 34.6800 helps spot resistance levels. Track Veracyte Inc performance using the live chart.
What are Veracyte Inc stock lowest prices?
The lowest price of Veracyte Inc (VCYT) over the year was 33.1100. Comparing it with the current 33.8500 and 33.1100 - 50.7100 shows potential long-term entry points. Watch VCYT moves on the chart live for more details.
When did VCYT stock split?
Veracyte Inc has gone through stock splits historically. These changes are visible in , 34.6800, and -8.27% after corporate actions.
- Previous Close
- 34.6800
- Open
- 33.3400
- Bid
- 33.8500
- Ask
- 33.8530
- Low
- 33.1100
- High
- 34.2800
- Volume
- 2.629 K
- Daily Change
- -2.39%
- Month Change
- -4.75%
- 6 Months Change
- -8.27%
- Year Change
- -8.27%